BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

They're calling it "silent" because the wave follows a long period of unusually low COVID activity this fall, so many people ...

Pfizer Inc. defeated a lawsuit from Texas Attorney General Ken Paxton that alleged the pharmaceutical giant misrepresented ...

Vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public.

CEPI grant aims to build on evidence of Micron Biomedical’s needle-free delivery of vaccines to bring CastleVax’s novel rapid ...

The BNT162b2 XBB vaccine shows 68% effectiveness in children aged 5-11 and 63% in those aged 12-17 against severe COVID-19 outcomes. The study involved 15,233 children, with a diverse demographic ...

Now, as families and friends gather for the holidays, providing a fertile mix of travel, tight spaces, and close contact, ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

The timeframe for people injured by COVID-19 "countermeasures," such ... Some are skeptical of the vaccine's effectiveness and others believe its contents produce irreparable side effects and ...